Tyra Biosciences, Inc. SEC filings TYRA

Tyra Biosciences, Inc. has 426 filings in SEC EDGAR's recent list, going back to May 28, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (other events). The company's fiscal year ends on December 31.

Tyra Biosciences, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Sep 21, 2026 —
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 17, 2026 —
4 Insider transaction Sep 17, 2026 Sep 15, 2026
SCHEDULE 13G Ownership over 5% (passive) Sep 17, 2026 —
8-K Current report
Other events
Sep 15, 2026 Sep 14, 2026
424B5 Prospectus supplement Sep 15, 2026 —
FWP Free writing prospectus Sep 14, 2026 —
S-3ASR Automatic shelf registration Sep 14, 2026 —
4 Insider transaction Sep 11, 2026 Sep 9, 2026
8-K Current report
Other events
Sep 9, 2026 Sep 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
424B5 Prospectus supplement Aug 4, 2026 —
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 30, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
8-K Current report
Shareholder vote results
Jun 2, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
144 Notice of proposed sale Jun 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
144 Notice of proposed sale May 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2026 —
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 24, 2026 —
4 Insider transaction Apr 20, 2026 Apr 16, 2026
3 Initial insider ownership Apr 20, 2026 Apr 16, 2026
ARS Annual report to shareholders Apr 17, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 17, 2026 —
DEF 14A Proxy statement Apr 17, 2026 May 28, 2026
8-K Current report
Officer or director change
Apr 17, 2026 Apr 16, 2026
144 Notice of proposed sale Apr 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 7, 2026 —
3 Initial insider ownership Apr 2, 2026 Apr 1, 2026
8-K Current report
Officer or director change
Apr 2, 2026 Apr 1, 2026
4 Insider transaction Mar 27, 2026 Mar 25, 2026
144 Notice of proposed sale Mar 26, 2026 —
144 Notice of proposed sale Mar 25, 2026 —
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
144 Notice of proposed sale Mar 12, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 6, 2026 —
8-K Current report
Other events
Mar 4, 2026 Mar 4, 2026
10-K Annual report Mar 2, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 2, 2026 Mar 2, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 20, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 13, 2026 Feb 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
144 Notice of proposed sale Feb 12, 2026 —
4 Insider transaction Jan 20, 2026 Jan 12, 2026
144 Notice of proposed sale Jan 12, 2026 —
4 Insider transaction Dec 19, 2025 Dec 19, 2025
4 Insider transaction Dec 16, 2025 Dec 12, 2025
144 Notice of proposed sale Dec 12, 2025 —
4 Insider transaction Dec 1, 2025 Dec 1, 2025
3 Initial insider ownership Dec 1, 2025 Dec 1, 2025
8-K Current report
Officer or director change
Dec 1, 2025 Nov 25, 2025
4 Insider transaction Nov 25, 2025 Nov 21, 2025
144 Notice of proposed sale Nov 21, 2025 —
4 Insider transaction Nov 19, 2025 Nov 18, 2025
144 Notice of proposed sale Nov 18, 2025 —
4 Insider transaction Nov 17, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
144 Notice of proposed sale Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
144 Notice of proposed sale Nov 13, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
4 Insider transaction Sep 17, 2025 Sep 15, 2025
8-K Current report
Other events
Aug 22, 2025 Aug 21, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 7, 2025 Aug 7, 2025
4 Insider transaction Aug 7, 2025 Aug 7, 2025
4 Insider transaction Aug 7, 2025 Aug 7, 2025
4 Insider transaction Aug 7, 2025 Aug 7, 2025
8-K Current report
Other events
Jun 30, 2025 Jun 30, 2025
4 Insider transaction Jun 20, 2025 Jun 17, 2025
144 Notice of proposed sale Jun 18, 2025 —
144 Notice of proposed sale Jun 17, 2025 —
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
144 Notice of proposed sale Jun 16, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 12, 2025 —
4 Insider transaction Jun 11, 2025 Jun 9, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 6, 2025 —
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
8-K Current report
Shareholder vote results
May 29, 2025 May 29, 2025
EFFECT Filing May 16, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 14, 2025 —
CORRESP Letter to the SEC May 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 14, 2025 —
UPLOAD Letter from the SEC May 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
S-3 Shelf registration May 8, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 18, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 18, 2025 —
DEF 14A Proxy statement Apr 18, 2025 May 29, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 31, 2025 —
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
SCHEDULE 13G Ownership over 5% (passive) Mar 6, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 7, 2025 Feb 5, 2025
144 Notice of proposed sale Feb 5, 2025 —
144 Notice of proposed sale Feb 5, 2025 —
4 Insider transaction Jan 31, 2025 Jan 29, 2025
3 Initial insider ownership Jan 31, 2025 Jan 29, 2025
8-K Current report
Officer or director change
Jan 29, 2025 Jan 28, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
144 Notice of proposed sale Jan 22, 2025 —
4 Insider transaction Jan 21, 2025 Jan 16, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 21, 2025 —
144 Notice of proposed sale Dec 9, 2024 —
SC 13D/A Amended ownership over 5% (active) Dec 6, 2024 —
144 Notice of proposed sale Dec 5, 2024 —
144 Notice of proposed sale Dec 2, 2024 —
4 Insider transaction Nov 26, 2024 Nov 25, 2024
144 Notice of proposed sale Nov 20, 2024 —
SC 13D/A Amended ownership over 5% (active) Nov 19, 2024 —
144 Notice of proposed sale Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13D/A Amended ownership over 5% (active) Nov 13, 2024 —
4 Insider transaction Nov 13, 2024 Nov 8, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
4 Insider transaction Nov 8, 2024 Nov 6, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
4 Insider transaction Nov 6, 2024 Nov 4, 2024
4 Insider transaction Nov 1, 2024 Oct 30, 2024
4 Insider transaction Nov 1, 2024 Oct 30, 2024
144 Notice of proposed sale Oct 30, 2024 —
144 Notice of proposed sale Oct 30, 2024 —
144 Notice of proposed sale Oct 28, 2024 —
8-K Current report
Other events
Oct 28, 2024 Oct 28, 2024
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Oct 25, 2024 Oct 24, 2024
SC 13D/A Amended ownership over 5% (active) Oct 22, 2024 —
4 Insider transaction Oct 22, 2024 Oct 18, 2024
3 Initial insider ownership Oct 22, 2024 Oct 10, 2024
4 Insider transaction Oct 22, 2024 Oct 18, 2024
SC 13D/A Amended ownership over 5% (active) Oct 22, 2024 —
4 Insider transaction Oct 22, 2024 Oct 18, 2024
8-K Current report
Unregistered share sale
Oct 18, 2024 Oct 18, 2024
4 Insider transaction Oct 17, 2024 Oct 15, 2024
144 Notice of proposed sale Oct 16, 2024 —
SC 13D/A Amended ownership over 5% (active) Oct 15, 2024 —
SC 13D/A Amended ownership over 5% (active) Oct 15, 2024 —
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Sep 25, 2024 Sep 23, 2024
4 Insider transaction Sep 20, 2024 Sep 18, 2024
144 Notice of proposed sale Sep 20, 2024 —
144 Notice of proposed sale Sep 18, 2024 —
144 Notice of proposed sale Sep 18, 2024 —
144 Notice of proposed sale Sep 18, 2024 —
144 Notice of proposed sale Sep 18, 2024 —
144 Notice of proposed sale Sep 18, 2024 —
4 Insider transaction Sep 17, 2024 Sep 13, 2024
4 Insider transaction Sep 17, 2024 Sep 13, 2024
4 Insider transaction Sep 10, 2024 Sep 9, 2024
3 Initial insider ownership Sep 10, 2024 Sep 9, 2024
4 Insider transaction Aug 16, 2024 Aug 14, 2024
4 Insider transaction Aug 16, 2024 Aug 14, 2024
4 Insider transaction Aug 16, 2024 Aug 14, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TYRA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carlsbad, CA
SEC filer status
, Emerging growth company
SEC CIK
1863127

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.